{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:01:56Z","timestamp":1789628516785,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2598,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1038\/modpathol.2015.118","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T07:41:20Z","timestamp":1446795680000},"page":"1555-1573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP"],"prefix":"10.1016","volume":"28","author":[{"given":"Zijun Y","family":"Xu-Monette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouthaina S","family":"Dabaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifeng","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganiraju C","family":"Manyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Tzankov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Visco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Dybkaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youli","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6250-048X","authenticated-orcid":false,"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5765-6631","authenticated-orcid":false,"given":"Kristy L","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William WL","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Han","family":"van Krieken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooryung","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s JM","family":"Ferreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben M","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane N","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A","family":"Piris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto N","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken H","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2015.118_bib1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/1947601910377798","article-title":"MYC inactivation elicits oncogene addiction through both tumor cell-intrinsic and host-dependent mechanisms","volume":"1","author":"Felsher","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1038\/modpathol.2015.118_bib2","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"10.1038\/modpathol.2015.118_bib3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2012-02-412783","article-title":"Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy","volume":"120","author":"Chesi","year":"2012","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.118_bib4","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1182\/blood-2013-05-498329","article-title":"Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification","volume":"122","author":"Ott","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.118_bib5","doi-asserted-by":"crossref","first-page":"e33813","DOI":"10.1371\/journal.pone.0033813","article-title":"Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas","volume":"7","author":"Kluk","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/modpathol.2015.118_bib6","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/PAS.0b013e318244e2ba","article-title":"High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma","volume":"36","author":"Green","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.118_bib7","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2559.2011.03978.x","article-title":"Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas","volume":"59","author":"Tapia","year":"2011","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.118_bib8","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/PAS.0000000000000433","article-title":"MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC\/BCL2 protein double-positive diffuse large B-cell lymphoma","volume":"39","author":"Wang","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.118_bib9","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjh.13276","article-title":"A clinician's guide to double hit lymphomas","volume":"168","author":"Cheah","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2015.118_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/PAS.0000000000000319","article-title":"Diffuse large B-cell lymphomas of immunoblastic type are a major reservoir for MYC-IGH translocations","volume":"39","author":"Horn","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.118_bib11","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","volume":"28","author":"Barrans","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2015.118_bib12","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","volume":"114","author":"Savage","year":"2009","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.118_bib13","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","article-title":"MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma","volume":"121","author":"Horn","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.118_bib14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/jcp.2009.065227","article-title":"Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment","volume":"62","author":"Obermann","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2015.118_bib15","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/modpathol.2013.214","article-title":"Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP","volume":"27","author":"Tzankov","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.118_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3324\/haematol.2013.091827","article-title":"Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma","volume":"99","author":"Aukema","year":"2014","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2015.118_bib17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.leu.2404529","article-title":"Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas","volume":"21","author":"Bertrand","year":"2007","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.118_bib18","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1200\/JCO.2006.05.5897","article-title":"Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma","volume":"24","author":"van Imhoff","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2015.118_bib19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.humpath.2008.06.032","article-title":"BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome","volume":"40","author":"Tibiletti","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2015.118_bib20","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.118_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3324\/haematol.2012.066209","article-title":"Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study","volume":"98","author":"Visco","year":"2013","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2015.118_bib22","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Johnson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2015.118_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/bjh.12763","article-title":"MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab","volume":"165","author":"Perry","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2015.118_bib24","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","article-title":"MYC\/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.118_bib25","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2011.41.4342","article-title":"Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Green","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2015.118_bib26","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3324\/haematol.2013.086173","article-title":"MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"98","author":"Valera","year":"2013","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2015.118_bib27","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/leu.2015.43","article-title":"Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma","volume":"29","author":"Horn","year":"2015","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.118_bib28","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1200\/JCO.2012.44.4729","article-title":"Growing importance of MYC\/BCL2 immunohistochemistry in diffuse large B-cell lymphomas","volume":"30","author":"Pfreundschuh","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2015.118_bib29","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2015.118_bib30","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2015.118_bib31","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood-2013-01-480392","article-title":"MYC, BCL2, BCL6 in DLBCL: impact for clinics in the future?","volume":"121","author":"Thieblemont","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.118_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0065-230X(10)07006-5","article-title":"MYC in oncogenesis and as a target for cancer therapies","volume":"107","author":"Albihn","year":"2010","journal-title":"Adv Cancer Res"},{"key":"10.1038\/modpathol.2015.118_bib33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2012.08.026","article-title":"Transcriptional amplification in tumor cells with elevated c-Myc","volume":"151","author":"Lin","year":"2012","journal-title":"Cell"},{"key":"10.1038\/modpathol.2015.118_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cell.2012.08.033","article-title":"c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells","volume":"151","author":"Nie","year":"2012","journal-title":"Cell"},{"key":"10.1038\/modpathol.2015.118_bib35","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/leu.2012.83","volume":"26","author":"Visco","year":"2012","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.118_bib36","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1182\/blood-2012-05-433334","article-title":"Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study","volume":"120","author":"Xu-Monette","year":"2012","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.118_bib37","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood-2012-12-473702","article-title":"MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program","volume":"122","author":"Xu-Monette","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.118_bib38","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood-2012-10-461848","article-title":"CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.118_bib39","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/modpathol.2015.76","article-title":"Evaluation of NF-kappaB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions","volume":"28","author":"Ok","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.118_bib40","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.18632\/oncotarget.3343","article-title":"Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1038\/modpathol.2015.118_bib41","unstructured":"Li L, Xu-Monette ZY, Ok CY et al. Prognostic Impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma. Oncotarget; advance online publication, 30 June 2015 [e-pub ahead of print]."},{"key":"10.1038\/modpathol.2015.118_bib42","doi-asserted-by":"crossref","unstructured":"Liu Z, Xu-Monette ZY, Cao X et al. Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy. Mod Pathol; advance online publication, 7 August 2015 [e-pub ahead of print].","DOI":"10.1016\/j.clml.2015.04.087"},{"key":"10.1038\/modpathol.2015.118_bib43","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1182\/blood-2013-07-518605","article-title":"Cooperative transcriptional repression by BCL6 and BACH2 in germinal center B-cell differentiation","volume":"123","author":"Huang","year":"2014","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.118_bib44","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.4049\/jimmunol.1101235","article-title":"MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12\/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity","volume":"187","author":"Lu","year":"2011","journal-title":"J Immunol"},{"key":"10.1038\/modpathol.2015.118_bib45","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2014-04-566778","article-title":"Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma","volume":"125","author":"Iqbal","year":"2015","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.118_bib46","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1038\/bcj.2012.1","article-title":"MicroRNA signatures in B-cell lymphomas","volume":"2","author":"Di Lisio","year":"2012","journal-title":"Blood Cancer J"},{"key":"10.1038\/modpathol.2015.118_bib47","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1084\/jem.20121387","article-title":"BCL6 positively regulates AID and germinal center gene expression via repression of miR-155","volume":"209","author":"Basso","year":"2012","journal-title":"J Exp Med"},{"key":"10.1038\/modpathol.2015.118_bib48","doi-asserted-by":"crossref","unstructured":"Testoni M, Zucca E, Young KH et al. Genetic lesions in diffuse large B-cell lymphomas. Ann Oncol 2015;1069\u20131080.","DOI":"10.1093\/annonc\/mdv019"},{"key":"10.1038\/modpathol.2015.118_bib49","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.immuni.2008.04.002","article-title":"MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation","volume":"28","author":"Dorsett","year":"2008","journal-title":"Immunity"},{"key":"10.1038\/modpathol.2015.118_bib50","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1038\/onc.2011.15","article-title":"MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4","volume":"30","author":"Schramedei","year":"2011","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2015.118_bib51","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/leu.2011.263","article-title":"Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC","volume":"26","author":"Holien","year":"2012","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.118_bib52","doi-asserted-by":"crossref","first-page":"e46117","DOI":"10.1371\/journal.pone.0046117","article-title":"Role of Smad proteins in resistance to BMP-induced growth inhibition in B-cell lymphoma","volume":"7","author":"Huse","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/modpathol.2015.118_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12076","article-title":"SMAD regulatory networks construct a balanced immune system","volume":"139","author":"Malhotra","year":"2013","journal-title":"Immunology"},{"key":"10.1038\/modpathol.2015.118_bib54","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/nar\/gks1038","article-title":"Novel Smad proteins localize to IR-induced double-strand breaks: interplay between TGFbeta and ATM pathways","volume":"41","author":"Wang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/modpathol.2015.118_bib55","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/ni.2418","article-title":"The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers","volume":"13","author":"Calado","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1038\/modpathol.2015.118_bib56","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1002\/cncr.27396","article-title":"Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab","volume":"118","author":"Akyurek","year":"2012","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2015.118_bib57","doi-asserted-by":"crossref","unstructured":"Cai Q, Medeiros LJ, Young KH . MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management. Oncotarget 2015 [e-pub ahead of print].","DOI":"10.18632\/oncotarget.5774"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2015118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2015118","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222013424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222013424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2015118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:48:09Z","timestamp":1760230089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222013424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0893395222013424"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2015.118","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2015.118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}